An immunomodulatory and Myotrophic Formulation with Simultaneous Neurotrophic Properties for The Treatment of ALS and Multiple Sclerosis
Description
An Immunomodulatory Formulation consisting of Nf-Kappa B, TNF-A and IL-6 Suppressive protopanaxatriol Class glucopyranoside Analouges, A Neurotrophic Protobioside Analouge that Promotes Myelin Regeneration, A Myotrophic Bioceutical Extract with Partial SARM-Like Effects thus increasing Muscle Mass via Protein Synthesis Enhancement, via GDF-8 Suppression, increasing intramascular MGF and IGF-1 mRNA Expression and Enhancing Cholinergic Neuromascular Transmission Duration. By Inhibiting Pro-Inflammatory Cytokine Release and via increasing Selective Anabolism Formulation Serves as an Effective Adjunctive Treatment for ALS and Multiple Sclerosis.
Inventors: Erdal Can Alkoclar
Metehan Yesil
Resources
| Name |
Format |
Description |
Link |
|
11 |
|
https://download.data.public.lu/resources/an-immunomodulatory-and-myotrophic-formulation-with-simultaneous-neurotrophic-properties-for-the-treatment-of-als-and-multiple-sclerosis/20200423-085104/16-ms-ve-als.docx |
|
33 |
|
https://download.data.public.lu/resources/an-immunomodulatory-and-myotrophic-formulation-with-simultaneous-neurotrophic-properties-for-the-treatment-of-als-and-multiple-sclerosis/20200423-085631/201305306.pdf |
Tags
- sante
- sarm
- als
- myotrophic
- multiple-sclerosis
- immunomodulation
- neuromascular-efficiency
- health